| scholarly article | Q13442814 |
| P356 | DOI | 10.1126/SCIENCE.8420003 |
| P698 | PubMed publication ID | 8420003 |
| P50 | author | Pietro Ghezzi | Q46434981 |
| P2093 | author name string | M Sironi | |
| A Rustici | |||
| B Green | |||
| M Porro | |||
| R Faggioni | |||
| M Velucchi | |||
| S Quataert | |||
| P4510 | describes a project that uses | synthetic peptide | Q104631433 |
| P433 | issue | 5093 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 361-365 | |
| P577 | publication date | 1993-01-01 | |
| P1433 | published in | Science | Q192864 |
| P1476 | title | Molecular mapping and detoxification of the lipid A binding site by synthetic peptides | |
| P478 | volume | 259 |
| Q39001413 | A bioinspired peptide scaffold with high antibiotic activity and low in vivo toxicity |
| Q42767063 | A cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression |
| Q32060778 | Affinity-based screening of combinatorial libraries using automated, serial-column chromatography |
| Q54138508 | Antibacterial and anti-inflammatory agents that target endotoxin. |
| Q42074628 | Antimicrobial activity and membrane selective interactions of a synthetic lipopeptide MSI-843 |
| Q42276631 | Antimicrobial peptides for gram-negative sepsis: a case for the polymyxins |
| Q34528895 | Bactericidal activity of synthetic peptides based on the structure of the 55-kilodalton bactericidal protein from human neutrophils |
| Q30729119 | Biopanning of endotoxin-specific phage displayed peptides |
| Q35777677 | Can innate immunity be enhanced to treat microbial infections? |
| Q40471157 | Cellular functions during activation and damage by pathogens: Immunogold studies of the interaction of bacterial endotoxins with target cells |
| Q33836526 | Combination of antimicrobial and endotoxin-neutralizing activities of novel oleoylamines |
| Q71786739 | Conformation of polymyxin B analogs in DMSO from NMR spectra and molecular modeling |
| Q34345762 | Crystal structure of an endotoxin-neutralizing protein from the horseshoe crab, Limulus anti-LPS factor, at 1.5 A resolution. |
| Q37489546 | De novo design of potent antimicrobial peptides |
| Q41875375 | Designed beta-boomerang antiendotoxic and antimicrobial peptides: structures and activities in lipopolysaccharide. |
| Q31976294 | Designed beta-sheet-forming peptide 33mers with potent human bactericidal/permeability increasing protein-like bactericidal and endotoxin neutralizing activities |
| Q40548349 | Endotoxin inhibitor blocks heat exposure-induced expression of brain cytokine mRNA in aged rats |
| Q71691200 | Endotoxin inhibitor prevents sepsis-induced alterations in intestinal ion transport |
| Q34428328 | Endotoxin removal by affinity sorbents |
| Q39782539 | Group of peptides that act synergistically with hydrophobic antibiotics against gram-negative enteric bacteria. |
| Q71763133 | High affinity endotoxin-binding and neutralizing peptides based on the crystal structure of recombinant Limulus anti-lipopolysaccharide factor |
| Q39514784 | Influence of synthetic antiendotoxin peptides on lipopolysaccharide (LPS) recognition and LPS-induced proinflammatory cytokine responses by cells expressing membrane-bound CD14 |
| Q39913265 | Inhibition of Gene Expression inEscherichia coliby Antisense Phosphorodiamidate Morpholino Oligomers |
| Q35149887 | Initial efforts toward the optimization of arylomycins for antibiotic activity |
| Q33856365 | Kinetics of the interaction of endotoxin with polymyxin B and its analogs: a surface plasmon resonance analysis |
| Q71703926 | Lipopolysaccharide (LPS) neutralizing peptides reveal a lipid A binding site of LPS binding protein |
| Q33648928 | Mapping residue-specific contacts of polymyxin B with lipopolysaccharide by saturation transfer difference NMR: Insights into outer-membrane disruption and endotoxin neutralization |
| Q73822172 | Molecular dynamics study on lipid A from Escherichia coli: insights into its mechanism of biological action |
| Q34000667 | Neutralization of endotoxin in vitro and in vivo by a human lactoferrin-derived peptide |
| Q40550415 | Neutrophil-mediated tissue injury and its modulation. |
| Q40535998 | New strategies for combatting sepsis: the magic bullets missed the mark ... but the search continues |
| Q73202461 | Oral antibiotics as a novel therapy for arthritis: evidence for a beneficial effect of intestinal Escherichia coli |
| Q73586421 | Polymyxin B binds to anandamide and inhibits its cytotoxic effect |
| Q33197502 | Probing lipase/esterase libraries for lipid A hydrolases--discovery of biocatalysts for the detoxification of bacterially-expressed recombinant protein |
| Q60214185 | Production of stable isotope enriched antimicrobial peptides in Escherichia coli: an application to the production of a 15N-enriched fragment of lactoferrin |
| Q24676683 | Protection from endotoxic shock by EVK-203, a novel alkylpolyamine sequestrant of lipopolysaccharide |
| Q40706119 | Protective role of phospholipid oxidation products in endotoxin-induced tissue damage |
| Q54222088 | Recent advances in nanomedicine for sepsis treatment. |
| Q27735437 | Structure of HBP, a multifunctional protein with a serine proteinase fold |
| Q34010143 | Structure--activity relationships of polymyxin antibiotics |
| Q41866978 | Structure-function relationships in novel peptide dodecamerswith broad-spectrum bactericidal and endotoxin-neutralizing activities |
| Q40540884 | Synergistic Antipseudomonal Effects of Synthetic Peptide AMP38 and Carbapenems. |
| Q27729827 | The solution structure of the active domain of CAP18 — a lipopolysaccharide binding protein from rabbit leukocytes |
| Q34377237 | Titration calorimetric studies to elucidate the specificity of the interactions of polymyxin B with lipopolysaccharides and lipid A. |
| Q33267137 | Topomimetics of amphipathic beta-sheet and helix-forming bactericidal peptides neutralize lipopolysaccharide endotoxins |
| Q34324978 | Towards the rational design of Th1 adjuvants |
| Q33585340 | Treatment of sepsis: past and future avenues |
| Q27629371 | Two mutants of human heparin binding protein (CAP37): toward the understanding of the nature of lipid A/LPS and BPTI binding |
| Q37093311 | Zwitterionic chitosan for the systemic treatment of sepsis |
Search more.